Home · Stock Market

Half yearly audited accounts of ORIONINFU

(H/Y): As per un-audited half yearly accounts as on 31.12.11 (July'11 to Dec'11), the Company has reported net profit after tax of Tk. 15.14 million with EPS of Tk. 0.74 as against Tk. 21.66 million and Tk. 1.06 respectively for the same period of the previous year. Whereas net profit after tax was Tk. 4.79 million with EPS of Tk. 0.24 for the period of 3 months (Oct'11 to Dec'11) ended on 31.12.11 as against Tk. 11.93 million and Tk. 0.59 respectively for the same period of the previous year. Accumulated profit/(loss) of the Company was Tk. (194.19) million as on 31.12.11.

28.01.2012. 23:31

METROSPIN declared @15% bonus share.

(H/Y): As per un-audited half yearly accounts as on 31.12.11 (July'11 to Dec'11), the Company has reported net profit/(loss) after tax of Tk. (74.37) million with basic EPS of Tk. (1.80) as against Tk. 91.28 million and Tk. 2.20 (restated) respectively for the same period of the previous year. However, considering bonus share @ 15% for the year 2010-11, restated basic EPS is Tk. (1.56) as on 31.12.11 (July'11 to Dec'11) and Tk. 1.92 as on 31.12.10 (July'10 to Dec'10). 'Other Income' of the company was Tk. 0.007 million as on 31.12.11 (July'11 to Dec'11) which was Tk. 1.11 million as on 31.12.10 (July'10 to Dec'10). (cont.)

26.01.2012. 23:29

SEC NEWS.

Investors are requested to consider the following facts at the time of making investment decision in the Capital Market: 1. Without acquiring proper knowledge, information and experience regarding different aspects and matters of Capital Market, one should not invest in the Capital Market. 2. The gain or loss, whichever comes from the investment, it belongs to you. So, well-thought of investment decision based on knowledge and fundamentals of the securities may be real assistance to you. 3. Don't pay any heed to rumors at the time of trading shares; it may cause loss to you. Even spreading rumor is legally prohibited.

27.01.2012. 23:25

New Posts

  • No articles at the moment

New Comments

  • No comments at the moment